Rare diseases
Investigational molecules
Locations
Back to Slovakia15 clinical trials in Nove Mesto Nad Vahom, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)A study comparing furazidin and clindamycin for women with bacterial vaginosis
SlovakiaStudy of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness
SlovakiaStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
SlovakiaA Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease
SlovakiaStudy of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis
SlovakiaStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
SlovakiaStudy on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy
SlovakiaStudy on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy
SlovakiaStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
SlovakiaStudy on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis
SlovakiaA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
SlovakiaStudy of lutikizumab and ravagalimab in adults with moderate to severe rheumatoid arthritis
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in Stara Tura is focused on cardiovascular diseases, with studies involving adults who have atherosclerotic cardiovascular disease and chronic kidney disease. The research is aimed at better understanding how new treatments may lower the risk of serious heart-related events.
These trials are designed to assess whether new therapies can improve prevention of major cardiovascular complications and support better long-term outcomes.
The local research portfolio also addresses overlapping cardiovascular and kidney-related risk, reflecting the close connection between blood vessel disease, blood pressure control, and renal health. This work helps evaluate whether emerging treatments can reduce events such as heart attack, stroke, or heart failure.
In this setting, researchers are focusing on whether new therapies can offer stronger protection than standard care for patients most vulnerable to major cardiovascular events.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
